Tech Company Financing Transactions

AZTherapies Funding Round

Duopharma Biotech Berhad, Spinnaker Capital and DRADS Capital participated in a $33.6 million capital raise for AZTherapies. The round was recorded on 9/30/2020.

Transaction Overview

Company Name
AZTherapies
Announced On
9/30/2020
Transaction Type
Venture Equity
Amount
$33,600,000
Round
Undisclosed
Investors

Duopharma Biotech Berhad (Lead Investor)

Spinnaker Capital (Lead Investor)

DRADS Capital

ID Fund

Wexford Capital

Proceeds Purpose
We plan to use these proceeds to further expand our regulatory and pre-commercial activities, recruit and retain key members of our management team, and continue to develop our robust and innovative pipeline targeting neuroinflammation as the root cause of neurodegenerative diseases.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Clarendon St. 17th Floor
Boston, MA 02116
USA
Phone
(617) 318-3411
Website
www.aztherapies.com
Email Address
[email protected]
Overview
AZTherapies is an advanced clinical-stage biopharmaceutical company developing novel therapies that aim to fundamentally change neurodegenerative disease progression, extending normal cognition and function and improving quality of life in the aging population.
Profile
AZTherapies LinkedIn Company Profile
Social Media
AZTherapies Company Twitter Account
Company News
AZTherapies News
Facebook
AZTherapies on Facebook
YouTube
AZTherapies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
David Elmaleh
  David Elmaleh LinkedIn Profile  David Elmaleh Twitter Account  David Elmaleh News  David Elmaleh on Facebook
Chief Financial Officer
Brian Bartlett
  Brian Bartlett LinkedIn Profile  Brian Bartlett Twitter Account  Brian Bartlett News  Brian Bartlett on Facebook
Chief Medical Officer
Karen Reeves
  Karen Reeves LinkedIn Profile  Karen Reeves Twitter Account  Karen Reeves News  Karen Reeves on Facebook
Vice President
Philip Ashton-Rickardt
  Philip Ashton-Rickardt LinkedIn Profile  Philip Ashton-Rickardt Twitter Account  Philip Ashton-Rickardt News  Philip Ashton-Rickardt on Facebook
VP - Manufacturing
Ernest Penachio
  Ernest Penachio LinkedIn Profile  Ernest Penachio Twitter Account  Ernest Penachio News  Ernest Penachio on Facebook
VP - Operations
David Brazier
  David Brazier LinkedIn Profile  David Brazier Twitter Account  David Brazier News  David Brazier on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/30/2020: Seismic venture capital transaction
Next: 9/30/2020: XtalPi venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.